Alternatives to Lithium Carbonate If You Can't Fill Your Prescription

Important: Never stop Lithium Carbonate abruptly. Abrupt discontinuation of lithium can trigger a severe manic rebound episode. Any transition to an alternative medication must be supervised by your prescriber, who will typically implement a gradual taper and crossover plan. This guide is for informational purposes only—always consult your doctor before making any medication change.

Lithium Carbonate is the gold standard for bipolar disorder maintenance therapy, with more than 70 years of clinical evidence behind it. But situations arise where a patient cannot access it: a pharmacy out of their specific strength, a medical condition that makes lithium unsafe, intolerable side effects, or insurance coverage gaps. When a switch becomes necessary, there are well-studied alternatives available. Here is what you need to know.

Before Considering an Alternative: Exhaust Your Options First

If the reason for considering a switch is a pharmacy stock issue—not a medical reason—it is always worth exhausting your options before switching. Call multiple pharmacies, ask your pharmacist to special-order it, or use a service like medfinder.com to find which pharmacies nearby have your specific Lithium Carbonate dose in stock. Switching mood stabilizers is complex, carries risks of a mood episode during the transition, and may take weeks to stabilize. A temporary pharmacy inconvenience rarely justifies the risks of a switch.

Valproate / Divalproex Sodium (Depakote) — The Closest Alternative

Valproate (also sold as divalproex sodium, brand name Depakote) is considered the most pharmacologically similar alternative to lithium. It is FDA-approved for acute mania and bipolar maintenance, and clinical guidelines list it alongside lithium as a first-line mood stabilizer. Studies show comparable efficacy between valproate and lithium for maintenance therapy, with response rates around 53% for valproate vs. 38% for lithium in some head-to-head trials.

However, valproate has significant drawbacks that do not apply to lithium:

Teratogenicity: Valproate causes serious birth defects (neural tube defects, autism spectrum disorder) and is contraindicated in women of childbearing potential unless no adequate alternatives exist.

Weight gain and metabolic effects: Significant weight gain is common with valproate.

Liver toxicity risk: Requires liver function monitoring, especially in the first 6 months.

Hair loss: More common with valproate than lithium.

Valproate is available as a generic and widely stocked. For patients who cannot take lithium due to kidney disease, cardiac issues, or who are not women of childbearing age, valproate may be an appropriate first-line alternative.

Lamotrigine (Lamictal) — Best for Depression-Predominant Bipolar

Lamotrigine is FDA-approved for bipolar I disorder maintenance and is particularly effective at preventing depressive episodes. Unlike lithium, it has limited antimanic efficacy and should not be used as the sole treatment in patients with frequent or severe manic episodes. It is also an anticonvulsant used for epilepsy.

A major limitation: lamotrigine requires slow titration over 8 or more weeks to minimize the risk of serious skin reactions, including Stevens-Johnson Syndrome. This makes it unsuitable for rapid transitions. Lamotrigine has a favorable side effect profile (no significant weight gain, no need for blood level monitoring for efficacy) and is generally well-tolerated.

Quetiapine (Seroquel) — FDA-Approved for Bipolar Depression and Maintenance

Quetiapine is an atypical antipsychotic with FDA approval for bipolar mania, bipolar depression, and maintenance therapy. It can be started more quickly than lamotrigine and works for both manic and depressive phases. However, it causes significant sedation (especially at higher doses), weight gain, and metabolic side effects including elevated cholesterol and blood sugar. Quetiapine extended-release (Seroquel XR) is FDA-approved specifically for bipolar maintenance.

Aripiprazole (Abilify) — Good Metabolic Profile, Approved for Mania

Aripiprazole is an atypical antipsychotic FDA-approved for acute manic and mixed episodes of bipolar I disorder and for maintenance as an adjunct to lithium or valproate. It has a more favorable metabolic profile than quetiapine or olanzapine—less weight gain and less sedation. A long-acting injectable (Abilify Maintena) is available for patients with adherence challenges. Aripiprazole is less effective than lithium or quetiapine for bipolar depression.

Olanzapine (Zyprexa) — Effective for Acute Mania, High Metabolic Risk

Olanzapine is one of the most effective agents for acute mania, but it carries significant metabolic side effects—substantial weight gain, diabetes risk, and dyslipidemia. It is FDA-approved for acute mania and (in combination with fluoxetine) for bipolar depression. For long-term use, the metabolic risks must be weighed against benefit.

What Makes Lithium Unique—and Hard to Fully Replace

One of lithium's most clinically important benefits has no equivalent: anti-suicidal effect. Research shows lithium reduces suicide attempts by approximately 8.6-fold and completed suicides by 9-fold in patients with bipolar disorder—an effect not replicated by valproate or atypical antipsychotics. Patients at high suicide risk should discuss this with their prescriber before any switch is considered.

Additionally, lithium is the only mood stabilizer on the WHO's List of Essential Medicines, reflecting its unique evidence base after 70+ years of clinical use.

What to Discuss with Your Doctor Before Switching

Your bipolar polarity pattern: Do you have more manic relapses or depressive episodes? This significantly affects which alternative is best.

Your current lithium dose and how long you've been stable on it.

Whether the switch is temporary (stock issue) or permanent (side effects, medical change).

Any other medications you take (drug interactions differ significantly between alternatives).

Pregnancy status or plans (valproate is strictly contraindicated; lithium and others have pregnancy risks too).

Before concluding that a switch is necessary due to a stock issue, use medfinder to confirm no local pharmacies have your dose. See also: How to Find Lithium Carbonate in Stock Near You.